首页> 外文期刊>Journal of Medicinal Chemistry >Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.
【24h】

Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.

机译:脱水内酯大环内酯。 2.2,3-脱水-6-O-甲基11,12-氨基甲酸酯红霉素A类似物的合成和抗菌活性。

获取原文
获取原文并翻译 | 示例
       

摘要

A series of 3-descladinosyl-2,3-anhydro-6-O-methylerythromycin A 11, 12-cyclic carbazate analogues was prepared and evaluated for antibacterial activity. These 2,3-anhydro macrolides were found to be potent antibacterial agents in vitro against macrolide-susceptible organisms including Staphylococcus aureus 6538P, Streptococcus pyogenes EES61, and Streptococcuspneumoniae ATCC6303. These compounds were also very active against some organisms that show macrolide resistance (S. aureus A5177, S. pyogenes PIU2584, and S. pneumoniae 5649). The compounds generally showed poor activity against organisms with constitutive MLS resistance. Selected compounds were evaluated in vivo in mouse protection studies. Although most of the compounds tested in vivo showed poor efficacy, two compounds, 38 and 57, were more active than clarithromycin against S. pneumoniae ATCC6303.
机译:制备了一系列3-descladinosyl-2,3-anhydro-6-O-methylerythromycin A 11、12-环氨基甲酸酯类似物,并评估了其抗菌活性。这些2,3-脱水大环内酯类化合物在体外是对大环内酯类易感生物体(包括金黄色葡萄球菌6538P,化脓性链球菌EES61和肺炎链球菌ATCC6303)有效的抗菌剂。这些化合物还对某些表现出对大环内酯类耐药性的生物非常有活性(金黄色葡萄球菌A5177,化脓性链球菌PIU2584和肺炎链球菌5649)。这些化合物通常对具有组成型MLS抗性的生物体显示出较差的活性。在小鼠保护研究中对所选化合物进行了体内评估。尽管大多数在体内测试的化合物显示出较差的功效,但是两种化合物38和57对肺炎链球菌ATCC6303的活性比克拉霉素高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号